Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078987306> ?p ?o ?g. }
- W2078987306 endingPage "211" @default.
- W2078987306 startingPage "205" @default.
- W2078987306 abstract "The efficacy and safety of single-dose ivermectin (150-200 micrograms/kg) and albendazole (400 mg) treatment administered separately or in combination for Wuchereria bancrofti infections were assessed in 1996-98 in a randomized double-blind placebo-controlled field trial in Ghana: 1425 individuals from 4 lymphatic filariasis-endemic villages, 340 of whom were microfilaria (mf)-positive before treatment, were randomized into 4 groups to receive albendazole alone, ivermectin alone, combination of albendazole and ivermectin, or placebo, respectively. Individuals were followed for 5 days after treatment to record any adverse reactions, and the effect of treatment on microfilaraemia was monitored in night-blood samples after 3, 6 and 12 months. Treatment efficacy was analysed for 236 mf-positive individuals who had > or = 100 mf/mL of blood and who were also present for examination at 12 months after treatment. Compared to the placebo group, the ivermectin and combination groups both showed statistically significant reductions in geometric mean mf intensities at the follow-up examinations (to 6.7% and 0.9%, 9.9% and 6.9%, and 21.7% and 11.4% of pre-treatment levels, respectively, at 3, 6 and 12 months after treatment). Compared to the ivermectin group, however, the reduction in the combination group was significantly greater only at 3 months after treatment, but not after 6 or 12 months. The albendazole group showed a slow but non-significant reduction over the same period. Adverse reactions were few and mostly mild (no severe reactions were recorded), and no significant differences were observed between the treatment groups. Both ivermectin and combination treatment thus appeared effective and safe for treatment of lymphatic filariasis, but the difference in efficacy was minor and the study did not provide clear evidence for the combination drug therapy, as compared to ivermectin therapy alone, to be superior for control of lymphatic filariasis." @default.
- W2078987306 created "2016-06-24" @default.
- W2078987306 creator A5041307705 @default.
- W2078987306 creator A5068349933 @default.
- W2078987306 creator A5073909836 @default.
- W2078987306 date "2000-03-01" @default.
- W2078987306 modified "2023-09-25" @default.
- W2078987306 title "A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana" @default.
- W2078987306 cites W1978624539 @default.
- W2078987306 cites W1980068298 @default.
- W2078987306 cites W1991279333 @default.
- W2078987306 cites W1992481520 @default.
- W2078987306 cites W2005571221 @default.
- W2078987306 cites W2014082530 @default.
- W2078987306 cites W2020242104 @default.
- W2078987306 cites W2021069007 @default.
- W2078987306 cites W2028067695 @default.
- W2078987306 cites W2034925914 @default.
- W2078987306 cites W2054748362 @default.
- W2078987306 cites W2069108353 @default.
- W2078987306 cites W2110486035 @default.
- W2078987306 cites W2130914472 @default.
- W2078987306 cites W2147623316 @default.
- W2078987306 cites W2314515855 @default.
- W2078987306 cites W2396365845 @default.
- W2078987306 doi "https://doi.org/10.1016/s0035-9203(00)90278-5" @default.
- W2078987306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10897370" @default.
- W2078987306 hasPublicationYear "2000" @default.
- W2078987306 type Work @default.
- W2078987306 sameAs 2078987306 @default.
- W2078987306 citedByCount "61" @default.
- W2078987306 countsByYear W20789873062013 @default.
- W2078987306 countsByYear W20789873062014 @default.
- W2078987306 countsByYear W20789873062015 @default.
- W2078987306 countsByYear W20789873062016 @default.
- W2078987306 countsByYear W20789873062017 @default.
- W2078987306 countsByYear W20789873062018 @default.
- W2078987306 countsByYear W20789873062019 @default.
- W2078987306 countsByYear W20789873062020 @default.
- W2078987306 countsByYear W20789873062022 @default.
- W2078987306 countsByYear W20789873062023 @default.
- W2078987306 crossrefType "journal-article" @default.
- W2078987306 hasAuthorship W2078987306A5041307705 @default.
- W2078987306 hasAuthorship W2078987306A5068349933 @default.
- W2078987306 hasAuthorship W2078987306A5073909836 @default.
- W2078987306 hasConcept C126322002 @default.
- W2078987306 hasConcept C141071460 @default.
- W2078987306 hasConcept C142724271 @default.
- W2078987306 hasConcept C165901193 @default.
- W2078987306 hasConcept C168563851 @default.
- W2078987306 hasConcept C197934379 @default.
- W2078987306 hasConcept C203014093 @default.
- W2078987306 hasConcept C204787440 @default.
- W2078987306 hasConcept C27081682 @default.
- W2078987306 hasConcept C2776158911 @default.
- W2078987306 hasConcept C2776908094 @default.
- W2078987306 hasConcept C2777065887 @default.
- W2078987306 hasConcept C2777411658 @default.
- W2078987306 hasConcept C2777499811 @default.
- W2078987306 hasConcept C2777629521 @default.
- W2078987306 hasConcept C2778672586 @default.
- W2078987306 hasConcept C2779359454 @default.
- W2078987306 hasConcept C42219234 @default.
- W2078987306 hasConcept C42972112 @default.
- W2078987306 hasConcept C71924100 @default.
- W2078987306 hasConcept C90924648 @default.
- W2078987306 hasConceptScore W2078987306C126322002 @default.
- W2078987306 hasConceptScore W2078987306C141071460 @default.
- W2078987306 hasConceptScore W2078987306C142724271 @default.
- W2078987306 hasConceptScore W2078987306C165901193 @default.
- W2078987306 hasConceptScore W2078987306C168563851 @default.
- W2078987306 hasConceptScore W2078987306C197934379 @default.
- W2078987306 hasConceptScore W2078987306C203014093 @default.
- W2078987306 hasConceptScore W2078987306C204787440 @default.
- W2078987306 hasConceptScore W2078987306C27081682 @default.
- W2078987306 hasConceptScore W2078987306C2776158911 @default.
- W2078987306 hasConceptScore W2078987306C2776908094 @default.
- W2078987306 hasConceptScore W2078987306C2777065887 @default.
- W2078987306 hasConceptScore W2078987306C2777411658 @default.
- W2078987306 hasConceptScore W2078987306C2777499811 @default.
- W2078987306 hasConceptScore W2078987306C2777629521 @default.
- W2078987306 hasConceptScore W2078987306C2778672586 @default.
- W2078987306 hasConceptScore W2078987306C2779359454 @default.
- W2078987306 hasConceptScore W2078987306C42219234 @default.
- W2078987306 hasConceptScore W2078987306C42972112 @default.
- W2078987306 hasConceptScore W2078987306C71924100 @default.
- W2078987306 hasConceptScore W2078987306C90924648 @default.
- W2078987306 hasIssue "2" @default.
- W2078987306 hasLocation W20789873061 @default.
- W2078987306 hasLocation W20789873062 @default.
- W2078987306 hasOpenAccess W2078987306 @default.
- W2078987306 hasPrimaryLocation W20789873061 @default.
- W2078987306 hasRelatedWork W1575748120 @default.
- W2078987306 hasRelatedWork W1968766822 @default.
- W2078987306 hasRelatedWork W1982938879 @default.
- W2078987306 hasRelatedWork W2067933750 @default.
- W2078987306 hasRelatedWork W2109910614 @default.
- W2078987306 hasRelatedWork W2143075592 @default.